Cryo-Cell International, Inc. CCEL
AMEX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.13M | 31.13M | 31.28M | 31.57M | 31.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.13M | 31.13M | 31.28M | 31.57M | 31.75M |
| Cost of Revenue | 11.04M | 11.23M | 11.41M | 11.74M | 7.28M |
| Gross Profit | 20.09M | 19.90M | 19.87M | 19.83M | 24.47M |
| SG&A Expenses | 18.86M | 18.95M | 18.59M | 18.22M | 18.78M |
| Depreciation & Amortization | 736.50K | 737.70K | 743.50K | 751.50K | 763.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.94M | 31.23M | 31.09M | 31.08M | 27.42M |
| Operating Income | 189.30K | -103.90K | 191.40K | 482.30K | 4.33M |
| Income Before Tax | -1.91M | -2.55M | -2.80M | -2.34M | 1.45M |
| Income Tax Expenses | 36.90K | -81.50K | -135.40K | 92.30K | 1.93M |
| Earnings from Continuing Operations | -1.95 | -2.47 | -2.67 | -2.43 | -0.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.95M | -2.47M | -2.67M | -2.43M | -473.50K |
| EBIT | 189.30K | -103.90K | 191.40K | 482.30K | 4.33M |
| EBITDA | 1.16M | 871.10K | 1.17M | 1.47M | 5.32M |
| EPS Basic | -0.24 | -0.31 | -0.33 | -0.30 | -0.06 |
| Normalized Basic EPS | -0.12 | -0.15 | -0.14 | -0.12 | 0.16 |
| EPS Diluted | -0.24 | -0.31 | -0.34 | -0.31 | -0.07 |
| Normalized Diluted EPS | -0.12 | -0.15 | -0.14 | -0.12 | 0.16 |
| Average Basic Shares Outstanding | 32.23M | 32.22M | 32.25M | 32.28M | 32.29M |
| Average Diluted Shares Outstanding | 32.23M | 32.24M | 32.31M | 32.45M | 32.47M |
| Dividend Per Share | 0.00 | 0.00 | 0.15 | 0.40 | 0.65 |
| Payout Ratio | 0.00% | 0.00% | -45.43% | -133.01% | -1,109.12% |